Status:
RECRUITING
Esophageal Cancer Multimodal Prehabilitation Study
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Esophageal Cancer
Esophageal Neoplasms
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The goal of this research study is to investigate the feasibility of implementing a prehabilitation program that aims to improve a patient's physical, nutritional, and sleep health before surgery in a...
Detailed Description
This research study is to test whether a novel, 4-week surgical multimodal prehabilitation protocol is feasible in at-risk older adult patients who have previously undergone neoadjuvant chemotherapy o...
Eligibility Criteria
Inclusion
- 65 years of age and over
- Adult male or non-pregnant female volunteers
- Completed neoadjuvant chemotherapy or radiotherapy for esophageal cancer
- At least four weeks to esophageal cancer surgery
- Without skin conditions that preclude wearing sensors
- Able to speak English and consent
Exclusion
- Participants in any other interventional study that may bias results or limit study adherence during our study
- Dietary restrictions that prevent consumption of nutritional supplements
- Women who are pregnant, nursing, or at risk of becoming pregnant
- Profound physical disability (for example, quadriplegia) that precludes participation in any aerobic or strength training.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06027515
Start Date
December 1 2023
End Date
January 31 2026
Last Update
November 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02215